A Phase 3 clinical trial of MLD-55 in pediatric patients with depression
Latest Information Update: 29 Sep 2022
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 22 Dec 2021 New trial record